Deals this week: Marina Biotech, Strekin, H. Lundbeck

Marina Biotech has acquired Prestalia, a drug indicated for the treatment of hypertension to low blood pressure from Symplmed Pharmaceuticals.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news